Costa-Silva, Tales Alexandre 
; Costa, Iris Munhoz ; Biasoto, Henrique Pellin; Lima, Guilherme M; Silva, Carolliny M; Pessoa Junior, Adalberto ; Monteiro, Gisele
Source: Blood Reviews. Unidade: FCF
Subjects: BIOFARMACOLOGIA, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA-SILVA, Tales Alexandre et al. Critical overview of the main features and techniques used for the evaluation of the clinical applicability of L-asparaginase as a biopharmaceutical to treat blood cancer. Blood Reviews, v. 43, p. 1-17 art. 100651, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.blre.2020.100651. Acesso em: 18 nov. 2024.APA
Costa-Silva, T. A., Costa, I. M., Biasoto, H. P., Lima, G. M., Silva, C. M., Pessoa Junior, A., & Monteiro, G. (2020). Critical overview of the main features and techniques used for the evaluation of the clinical applicability of L-asparaginase as a biopharmaceutical to treat blood cancer. Blood Reviews, 43, 1-17 art. 100651. doi:10.1016/j.blre.2020.100651NLM
Costa-Silva TA, Costa IM, Biasoto HP, Lima GM, Silva CM, Pessoa Junior A, Monteiro G. Critical overview of the main features and techniques used for the evaluation of the clinical applicability of L-asparaginase as a biopharmaceutical to treat blood cancer [Internet]. Blood Reviews. 2020 ; 43 1-17 art. 100651.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.blre.2020.100651Vancouver
Costa-Silva TA, Costa IM, Biasoto HP, Lima GM, Silva CM, Pessoa Junior A, Monteiro G. Critical overview of the main features and techniques used for the evaluation of the clinical applicability of L-asparaginase as a biopharmaceutical to treat blood cancer [Internet]. Blood Reviews. 2020 ; 43 1-17 art. 100651.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.blre.2020.100651
